Hospice Care in Hawaii - Ratings, Address, Contact
9 Hospice found. Showing 1 - 9
 Hospice Of Hilo Medicare Approved Location: 1011 Waianuenue Avenue, Hilo, Hawaii 96720 Phone: (808) 969-1733 |
St Francis Hospice Medicare Approved Location: 24 Puiwa Road, Honolulu, Hawaii 96817 Phone: (808) 595-7566 |
|
Bristol Hospice - Hawaii, Llc Medicare Approved Location: 500 Ala Moana Boulevard, Suite 4-545 And 547, Honolulu, Hawaii 96813 Phone: (801) 536-8012 |
Islands Hospice Medicare Approved Location: 1301 Young St, Honolulu, Hawaii 96814 Phone: (808) 550-2552 |
Hospice Of Kona Medicare Approved Location: 75-5925 Walua Road, Suite 101, Kailua Kona, Hawaii 96740 Phone: (808) 324-7700 |
North Hawaii Hospice, Inc Medicare Approved Location: 65-1328 Kauaihae Road, Kamuela, Hawaii 96743 Phone: (808) 885-7547 |
Kauai Hospice Medicare Approved Location: 4457 Pahe'e Street, Lihue, Hawaii 96766 Phone: (808) 245-7277 |
Hospice Maui Medicare Approved Location: 400 Mahalani Street, Wailuku, Hawaii 96793 Phone: (808) 244-5555 |
News Archive
Oversize waistlines are a potent risk factor for heart disease in women
A heart expert at Johns Hopkins is calling for all women with a waistline measuring more than 35 inches to get an annual check-up and detailed risk assessment for heart problems because excess abdominal fat, even in the mildly obese and overweight, leads more than a third of women to underestimate their lifetime risk of having a heart attack, stroke or chest pain (angina).
Use of lubricants with anal sex associated with increased risk of rectal sexually transmitted infections
The risk of acquiring HIV through unprotected anal sex is at least 20 times greater than with unprotected vaginal sex and increases if other infections are already present in the rectal lining. Could the use of lubricants - at least certain kinds - be another risk factor among men and women who engage in receptive anal intercourse? Two studies presented today at the International Microbicides Conference in Pittsburgh, suggest the answer is yes.
Schering and MSP Singapore sue Mylan over generic Vytorin ANDA
Mylan Inc. today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Schering Corporation and MSP Singapore Company in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg. This product is the generic version of Vytorin® Tablets, a cholesterol treatment.
50% of Canadians with dementia are not diagnosed early enough
As many as 50 per cent of Canadians with dementia are not diagnosed early enough,* losing precious time when care and support can make a tremendous difference in their quality of life and avert unnecessary crises for their families.
› Verified 5 days ago